Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 08:02 am Purchase | 2022-12-31 | 13G | Oncorus, Inc. ONCR | Citadel Advisors LLC | 2,017,854 7.800% | 116,545 (+6.13%) | Filing History |
| 2023-02-13 12:36 pm Purchase | 2022-12-31 | 13G | Oncorus, Inc. ONCR | CHI Advisors LLC | 2,367,436 9.110% | 260,533 (+12.37%) | Filing History |
| 2023-02-02 2:15 pm Purchase | 2022-12-31 | 13G | Oncorus, Inc. ONCR | Arkin Moshe | 2,508,481 9.660% | 1,041,392 (+70.98%) | Filing History |
| 2023-01-18 7:57 pm Sale | 2023-01-17 | 13D | Oncorus, Inc. ONCR | James E. Flynn | 1,015,154 3.910% | -566,397 (-35.81%) | Filing History |
| 2023-01-13 6:47 pm Sale | 2023-01-11 | 13D | Oncorus, Inc. ONCR | James E. Flynn | 1,581,551 6.090% | -954,635 (-37.64%) | Filing History |
| 2022-12-30 7:15 pm Sale | 2022-12-22 | 13D | Oncorus, Inc. ONCR | James E. Flynn | 2,536,186 9.760% | -470,747 (-15.66%) | Filing History |
| 2022-12-21 7:05 pm Purchase | 2022-12-19 | 13D | Oncorus, Inc. ONCR | James E. Flynn | 3,006,933 11.580% | 157,963 (+5.54%) | Filing History |
| 2022-11-01 4:06 pm Purchase | 2022-04-01 | 13G | Oncorus, Inc. ONCR | K2 HealthVentures Equity Trust LLC | 2,593,767 9.100% | 2,593,767 (New Position) | Filing History |
| 2022-07-08 4:56 pm Sale | 2022-06-30 | 13G | Oncorus, Inc. ONCR | BlackRock Inc. BLK | 278,740 1.100% | -1,075,269 (-79.41%) | Filing History |
| 2022-02-14 5:44 pm Sale | 2021-12-31 | 13G | Oncorus, Inc. ONCR | Perceptive Advisors LLC | 999,812 3.900% | -990,175 (-49.76%) | Filing History |
| 2022-02-14 06:12 am Purchase | 2021-12-31 | 13G | Oncorus, Inc. ONCR | Citadel Advisors LLC | 1,901,309 7.400% | 21,972 (+1.17%) | Filing History |
| 2022-02-11 1:51 pm Purchase | 2021-12-31 | 13G | Oncorus, Inc. ONCR | CHI Advisors LLC | 2,106,903 8.160% | 426,997 (+25.42%) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Oncorus, Inc. ONCR | BlackRock Inc. BLK | 1,354,009 5.200% | 1,354,009 (New Position) | Filing History |
| 2021-12-02 4:15 pm Purchase | 2021-11-22 | 13G | Oncorus, Inc. ONCR | Arkin Moshe | 1,467,089 5.680% | 1,467,089 (New Position) | Filing History |
| 2021-03-02 3:37 pm Purchase | 2020-12-31 | 13G | Oncorus, Inc. ONCR | CHI Advisors LLC | 1,679,906 6.600% | 1,679,906 (New Position) | Filing History |
| 2021-02-16 4:30 pm Purchase | 2020-12-31 | 13G | Oncorus, Inc. ONCR | Citadel Advisors LLC | 1,879,337 8.300% | 26,688 (+1.44%) | Filing History |
| 2021-02-16 3:46 pm Purchase | 2020-12-31 | 13G | Oncorus, Inc. ONCR | Perceptive Advisors LLC | 1,989,987 7.700% | 1,989,987 (New Position) | Filing History |
| 2020-10-21 4:05 pm Purchase | 2020-10-06 | 13D | Oncorus, Inc. ONCR | MPM BioVentures 2014, L.P. | 5,296,279 24.200% | 5,296,279 (New Position) | Filing History |
| 2020-10-16 12:22 pm Purchase | 2020-10-06 | 13D | Oncorus, Inc. ONCR | James E. Flynn | 2,848,970 13.040% | 2,848,970 (New Position) | Filing History |
| 2020-10-13 4:08 pm Purchase | 2020-10-02 | 13G | Oncorus, Inc. ONCR | Citadel Advisors LLC | 1,852,649 8.500% | 1,852,649 (New Position) | Filing History |